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Background: The adhesion of lactobacilli to the vaginal surface is of paramount importance to develop their
probiotic functions. For this reason, the role of HeLa cell surface proteoglycans in the attachment of Lactobacillus
salivarius Lv72, a mutualistic strain of vaginal origin, was investigated.
Results: Incubation of cultures with a variety of glycosaminoglycans (chondroitin sulfate A and C, heparin and
heparan sulfate) resulted in marked binding interference. However, no single glycosaminoglycan was able to
completely abolish cell binding, the sum of all having an additive effect that suggests cooperation between them
and recognition of specific adhesins on the bacterial surface. In contrast, chondroitin sulfate B enhanced cell to cell
attachment, showing the relevance of the stereochemistry of the uronic acid and the sulfation pattern on binding.
Elimination of the HeLa surface glycosaminoglycans with lyases also resulted in severe adherence impairment.
Advantage was taken of the Lactobacillus-glycosaminoglycans interaction to identify an adhesin from the bacterial
surface. This protein, identify as a soluble binding protein of an ABC transporter system (OppA) by MALDI-TOF/(MS),
was overproduced in Escherichia coli, purified and shown to interfere with L. salivarius Lv72 adhesion to HeLa cells.
Conclusions: These data suggest that glycosaminoglycans play a fundamental role in attachment of mutualistic
bacteria to the epithelium that lines the cavities where the normal microbiota thrives, OppA being a bacterial
adhesin involved in the process.
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The vaginal microbiota of healthy women of reproduc-
tive age is dominated by lactobacilli. Their proportion in
this habitat is consistently higher than 70%, in some cases
being practically exclusive [1-3]. The evidence compiled
about the mutualistic role of lactobacilli on the mucous
membranes, together with their harmlessness, has pro-
moted their use as probiotic agents [4]. Isolates obtained
from feces, vaginal exudates and even mucous membranes
resulting from surgery, have been tested for epithelial
adherence, acid, bacteriocin and H2O2 production and
lack of transmissible antibiotic resistances with the aim of* Correspondence: quirosluis@uniovi.es
1Área de Microbiología, Universidad de Oviedo, Julián Clavería 6 33006
Oviedo, Spain
4Instituto Univesitario de Oncología del Principado de Asturias (IUOPA),
Universidad de Oviedo, Oviedo, Spain
Full list of author information is available at the end of the article
© 2013 Martín et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orunderstanding the basis of their interaction with the
mucosal surfaces and, ultimately, using them as probiotic
agents [1,2].
Adherence to the epithelium of the cavity to be colo-
nized is of paramount importance to compete with
colonization by potential pathogens and to avoid sweep-
ing by the circulating fluids. Impairment of adherence
by treatment of microbial or epithelial cells with prote-
ases, lipases or periodic acid suggested that the bacterial
adhesins and cellular receptors are proteins, lipids or
polysaccharides respectively [5-8]. Furthermore, identifi-
cation of the proteins secreted by the bacteria and those
anchored to its cell wall has provided lists of polypeptides
putatively involved in mucous adherence. Curiously, this
approach has identified enzymes related to sugar catabo-
lism, such as glyceraldehyde-3-phosphate dehydrogenase
and enolase [9-12].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ubiquitous on the surface of the epithelial cells while
showing enough variability as to account for the ob-
served organotropism shown. These conditions are met
by proteoglycans (PGs), which are made up of specific
protein cores covalently bound to linear polysaccharides
named glycosaminoglycans (GAGs). The GAGs are built
of repeat disaccharide subunits, whose composition al-
lows their classification into different groups: i) heparin/
heparan sulphate (HS), containing glucuronic acid (GlcA)
and N-acetyl glucosamine (GlcNAc); ii) chondroitin/der-
matan sulphate (CS/DS), where GlcA is replaced by N-
acetylgalactosamine (GalNAc); iii) keratan sulphate, with
galactose and GlcNAc, and iv) hyaluronic acid (HA), with
the same disaccharide unit as HS, but unmodified and
devoid of the protein stem.
During their biosynthesis, all GAGs but HA undergo
different modification reactions that can involve N-de
acetylations, epimerizations and various O-sulfations.
The structure of the GAG chains expressed is regulated
and dynamically adapted. To perform this task, multiple
isoenzymes can perform the catalysis [13-15]. Each iso-
enzyme shows particular substrate specificity, and their
expression vary depending on the cells, the tissues, the
state of development and the physiological and patho-
logical conditions.
A variety of functions have been ascribed to PGs, in-
cluding cell adhesion and migration, organization of the
cytoskeleton and of the extracelullar matrix (ECM), regu-
lation of proliferation, differentiation and morphogenesis,
and tissue repair and inflammation [16-18]. Furthermore,
they act as co-receptors for multiple soluble ligands in-
cluding cytokines, chemokines, growth factors, enzymes
and enzyme inhibitors, thus collaborating in intercellular
communication and tissue differentiation [16,19,20].
PGs in general and especially those with heparan sul-
phate (HSPGs) have been proposed as the receptors that
facilitate recognition and binding between eukaryotic
membranes and microbial pathogens, including bacteria,
viruses and protozoa. Their role as receptors for Neisseria
meningitidis [21], N. gonorrhoeae [22,23], Mycobacterium
tuberculosis [24], Enterococcus faecalis [25], Listeria mono
cytogenes [26], Streptococcus and Staphylococcus [27], Bru-
cella [28], Escherichia coli [29] and even intracellular para-
sites such as Chlamidia pneumoniae [30] have been
described. Besides this, it seems that binding of group A
streptococci to GAGs leads to a cytoskeleton conform-
ational change that allows pathogen penetration [31,32].
The requirement of GAGs for viral infection has been dem-
onstrated, among others, for papilloma virus [33], herpes
virus [34], and HIV [35]. Finally, it is known that GAGs
act as receptors for Toxoplasma gondii [36], Leishmania
[37] and Plasmodium [38]. However, the microbial li-
gands involved in most of these processes have not yetbeen identified. This role of PGs as the eukaryotic recep-
tors for many pathogens is the basis of our initial hypoth-
esis which suggests the same function of these molecules
when interacting with autochthonous no pathogenic mi-
croorganisms such as lactobacilli.
In this report we provide data on the involvement of
GAGs in attachment of Lactobacillus salivarius Lv72, iso-
lated from a human vaginal exudate, to cultures of HeLa
cells. Based on these data, a bacterial adhesin was identi-
fied which, once purified, significantly interfered with
attachment of the lactobacilli to HeLa cell cultures.
Results
Interference of GAGs on HeLa cell-Lactobacillus salivarius
Lv72 adhesion
To study the role of GAGs on Lv72 adhesion to HeLa
cells, addition of commercial preparations of HS, heparin,
CS A or CS C to HeLa to cell monolayers was performed
immediately before the addition of exponentially growing
L. salivarius Lv72 cells. The results showed a decrease in
the adherence between them (Figure 1). This depletion, al-
though being dose dependent, does not follow a linear cor-
relation. The estimated dissociation constants (KD) were of
2.5 nM for HS, 6.8 nM for CS A, 39.9 nM for CS C and
280.9 nM for heparin, which indicates that the affinity of
the bacteria for the different receptors varied markedly, up
to two orders of magnitude between HS and heparin.
However, care must be taken with this interpretation, as
the KDs are approximate values. Surprisingly, CS B did not
produce any inhibitory effect, and even promoted a slight
increase in the adhesion (Figure 1). Remarkably, the
combined use of these GAGs dramatically increased the
inhibition, reaching values up to 85% and 90% at total
concentrations of 10 and 100 μg/ml respectively, al-
though this effect was not strictly additive (Figure 1A).
Effect of cell surface GAGs digestion on adherence
To investigate further the adherence of Lv72 to the GAGs,
cell surface GAGs were removed by digestion with bacter-
ial lyases, and the effect of this treatment on the binding
of the bacteria was determined. Treatment with chon-
droitinase ABC, which degrades the three CS variants,
resulted in reduced binding (Figure 2), slightly lower than
that observed for high concentrations of the GAGs in
the competition experiment. Furthermore, the concur-
rent degradation of heparan sulfate with heparinase I,
which cleaves at the linkages between hexosamines and
O-sulfated iduronic acids, heparinase III, which cleaves
at the linkages between hexosamine and glucuronic acid,
and heparinase II, which cleaves with lower selectivity link-
ages between hexosamines and uronic acid residues (both
glucuronic and iduronic), resulted in a decrease in binding
comparable to that obtained in competition experiments
(Figure 2). Moreover, the simultaneous degradation with
Figure 1 Inhibition of Lactobacillus attachment to HeLa cells by the presence of different GAGs. A) Adhesion of Lactobacillus salivarius
Lv72 to HeLa cells co-incubated in the presence of different concentrations of heparin (♦), HS (*), CS A (■), CS C (□), CS B (▲) and a mixture of all
GAGs except CS B (final concentration) (●). B) Detail of the inhibitory effect at concentrations below 1 μg /ml. n=9 ANOVA test **, p-value < 0.001; *,
p-value < 0.05 vs adhesion of Lactobacillus salivarius Lv72 to HeLa cells without interferences.
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effect that reduced the binding of the bacteria (Figure 2).
Differential effect of GAGs obtained from different cell
types on adherence interference
To study the influence of the cellular type, GAGs were
extracted from HeLa and HT-29 cell cultures and used
in adherence assays. The results showed that the mole-
cules isolated from human epithelial cells inhibited the
binding of the lactobacilli more efficiently than commer-
cially available GAGs, from pig or beef tissues (Figure 3A).
GAGs from HT-29 and HeLa cultures were three and ten
times more effective than the heterologous ones. Finally,
soluble HS and CS purified from HeLa cells have similar
effects on the adhesion of L. salivarius Lv 72 to HeLa cells
(Figure 3B).
Identification and testing of bacterial adhesins able to
bind GAGs
To identify the bacterial proteins involved in the inter-
action between L. salivarius Lv72 and eukaryotic GAGs,
the proteins of the bacterial envelope were solubilised and
subjected to affinity chromatography, using heparin as the
ligand. The fractions eluting at concentrations higher than
0.8 M NaCl were tested for their ability to interfere with
the HeLa – L. salivarius binding. Those showing high ac-
tivity were subjected to anion exchange chromatography.
One of the fractions recovered showed a high interfering
activity while presenting just one conspicuous protein
band upon SDS-PAGE analysis (Figure 4). This protein
was identified by MALDI-TOF (MS) analysis as a sol-
uble binding protein of an ABC transport system due toits homology with the protein OppA of Lactobacillus
salivarius UCC118 (GI/90962668) (9 queries matched,
10% sequence coverage). The gene encoding for L.
salivarius Lv72 OppA was cloned in E. coli, overexpressed
and purified by passage through a heparin affinity column.
The purified protein was used in interference adhesion
assays (Figure 5). The results obtained show that OppA
significantly interferes with the attachment of L. salivarius
Lv72 to HeLa cultures in a dose dependent way, thus
confirming its role as an adhesin in the interaction between
both cellular types.
Discussion
PGs are ubiquitous, being present in all cell types and in
the ECM. The enormous structural diversity of their GAG
chains and core proteins mediates specific interactions be-
tween many molecules. Because of these characteristics,
they play an essential role in the interaction between cells.
In addition, these molecules present properties which sug-
gest that they might be part of the receptors that allow the
attachment of the normal microbiota to the mucous epi-
thelia that line the digestive tract and the vagina. In fact,
many pathogenic microorganisms use these molecules as
specific receptors and in bacterial internalization during
the infective process [39,40].
The GAGs are involved on HeLa cell-Lactobacillus
salivarius Lv72 adhesion
To test the probiotic bacteria-PG receptor hypothesis, a
model was devised that involved HeLa cells, a line derived
from human genital epithelium, and a vaginal strain of
Lactobacillus salivarius, which was previously shown to
Figure 2 Effect of the pre-treatment of HeLa cell cultures with
GAG lyases on attachment of L. salivarius Lv72. HeLa cells were
treated with heparinases, chondroitinase ABC or heparinises +
chondroitinase ABC before the co-incubation with the lactobacilli.
n=9 ANOVA test **, p-value < 0.001; *, p-value < 0.05.
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taken when interpreting these results, as HeLa cell line
has been found to be unstable and its gene expression
profiles differ from those in normal human tissues [41].
The experiments involved the GAGs HS, CS A, and
CS C, usually present on the cell surface as part of PGs
such as syndecans, glypicans, betaglycan or different iso-
forms of CD44. Heparin (an oversulfated form of HS) and
CS B (DS) were also included in the studies. The results in-
dicate that all these GAGs with the exception of CS B were
able to efficiently interfere with L. salivarius binding, the
effect ranging between 50% and 60% for heparin and CS A
and C respectively. Their combined effects were nearly
additive, the mixture of all species rising to 90% inhibition
of the bacterial binding. These data were confirmed by theobservation that enzymatic elimination of surface GAGs
resulted in blockage of L. salivarius attachment to the HeLa
cell cultures.
However, residual attachment always remained after
GAG interference or digestion suggesting that other
eukaryotic receptors may be involved. In fact, cell-
associated ECM proteins such as fibronectin, laminin
and collagen have been identified as receptors, especially
for pathogenic bacteria [42-44] and also for vaginal and
intestinal lactobacilli [45,46]. In addition, direct binding
between lactobacilli and glycolipids of the epithelial cell
membranes appear to contribute to the attachment, in a
process mediated by divalent cations [47]. Finally, non-
specific factors might also contribute to cell to cell ad-
herence, especially superficial hydrophobicity established
between membrane exposed patches of the eukaryotic
cell and components of the Gram positive cell wall,
especially teichoic acids [48].
L. salivarius Lv 72 has different affinity for the
different GAGs
In spite of the general effect of GAGs on bacterial attach-
ment, different molecules displayed apparent disparate
interference constants. Among the group of CSs, charac-
terized by being composed of uronic acid linked to the
third carbon of N-acetylgalactosamine, CS C appears to be
6 times more active than CS A. Conversely, CS B gener-
ated a binding increase. This might be due to the different
sulfation patterns shown; CS A and C are sulfated at C-4
and C-6 of the GalNAc moieties respectively, while CS B
is usually more extensively sulfated (Figure 6). Addition-
ally, the GlcA residue present in CS A and C is epimerized
to IdoA in CS B, which confers greater conformational
flexibility on the molecule [49]. The glucosaminoglycans
are represented by HS and heparin and are composed of
uronic acid linked to the fourth carbon of glucosamine. In
spite of their fundamental similarity, heparin displays an
apparent affinity that is lower than that of HS. The main
difference between these two molecules is that HS displays
IdoA rich regions of very high sulfation that can extend
from two to eight disaccharide units and are separated by
15 poorly sulfated GlcA rich disaccharide moieties [50].
Heparin, on the other hand, shows more extensive sul-
fation and uronic acid epimerization (Figure 6). Taken to-
gether, these data indicate that the regiochemistry of the
sulfation is crucial for affinity of the binding as evidenced
by the difference between the CS sulfated at C-4 or C-6, or
the significant difference between the oversulfated heparin
and the HS. Furthermore, the epimerization of the uronic
acid seems also to be crucial, based on the difference in
behavior induced by IdoA-rich species, such as heparin
and, particularly, CS B.
The high affinity of particular bacteria for HS and heparin
has been observed with several pathogens. For instance,
Figure 3 Inhibition of L. salivarius attachment to HeLa cells by the presence of GAGs of different origins. A) Relative adherence of the
lactobacilli to HeLa cells co-incubated in the presence of 100 μg/ml of total GAGs extracted from HeLa and HT-29 cells and from commercially
available, heterologous sources; n=9 ANOVA test **, p-value < 0.001; *, p-value < 0.05. B) Adhesion of L. salivarius Lv72 to HeLa cells co-incubated
in the presence of increasing concentrations of HS (X), CS (▲) and a mixture of both (♦) extracted from HeLa cell cultures, n=9 ANOVA test **,
p-value < 0.001; *, p-value < 0.05 vs adhesion of Lactobacillus salivarius Lv72 to HeLa cells without interferences.
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Enterococci and Listeria [25,51-53]. Conversely, heparin dis-
plays greater affinity for Chlamydia [54] while HS does
so for Pseudomonas [55]. The CSs are high affinity recep-
tors for Pneumococci [53] or Spirochetes [56] although they
do not bind to Chlamydia, Penicillium, Pseudomonas or
Listeria [51,52,54,55]. Interestingly, DS usually shows a dif-
ferent behavior compared to other molecular forms of
galactosaminoglycans, acting as receptor in Chlamydia,
Penicillium or Leptospira [52,54,57], although, to our know-
ledge, this is the first communication on an increase of bac-
terial binding in the presence of this molecule in solution.
The GAGs obtained from different cell types have
different effect on adherence
The fine structure of the GAGs differs according not
only to their nature, but also to the developmental phase
and the physiological and pathological conditions as well
as to the cellular type. This is especially noticeable for
HS, but also for CS/DS [50,58,59]. GAGs isolated from
HeLa and HT-29 cells notably increased the inhibition of
binding in comparison to the commercial forms, which
were isolated from bovine kidney (HS), bovine trachea
(CS A), shark cartilage (CS C) and porcine mucosa (CS B).
OppA protein is an adhesin involved in Lv 72 adhesion to
HeLa cells
Once the nature of the main eukaryotic cell receptors
was known, identification of bacterial adhesins became
easier because the prior could be employed as affinity li-
gands for the latter. In this way, using heparin as ligand, we
identified OppA, which strongly interfered with HeLa – L.salivarius attachment in a concentration dependent man-
ner. However, a plateau was reached which suggests that
other adhesins may exist and that they recognize non-
overlapping receptors as happens with Borrelia burgdorferi,
which presents 4 adhesins capable of GAG binding [56].
OppA is an externally exposed extracellular lipopro-
tein carrying a peptidase II signal for covalent anchoring
to the membrane [12] to which diverse roles have been
ascribed; it acts as the substrate-binding protein of the
oligopeptide transport system in lactobacilli [60], but has
also been implicated in cytoadhesion of Mycobacterium
hominis and Treponema denticolaria to eukaryotic cells
through interaction with plasminogen and fibronectin
respectively [61-63]. Furthermore, it has been found to
interact with fibronectin and collagen in Lactobacillus
casei BL23 and other OppA orthologues from lactoba-
cilli such as MapA from L. reuteri are able to interact
with Caco-2 [12,64]. The OppA-mediated cytoadhesion
of M. hominis to HeLa cells seems to be dependent on
the ATPase activity of the protein [63,65]. These prece-
dents and the data reported here on adhesion to GAGs,
indicate that OppA is a multifunctional protein that me-
diates the interaction of the bacteria with its environ-
ment. Attachment to the substrate may be a means of
accessing peptides that will subsequently be internalized
[66], especially for multiauxotrophic organisms such as
the lactobacilli.
Conclusion
In conclusion, the adherence of L. salivarius Lv72 to
HeLa cells is, at least in part, mediated by the interaction
Figure 4 Surface proteins of Lactobacillus salivarius Lv72 separated by means of heparin-affinity chromatography (A, C, E) and ionic
interchange chromatograpy (B, D, F). A,B) Chromatograms. The mark shows the fractions of interest that were tested further. C,D) Adherence
interference experiments: inhibitory effect of the fractions on Lv72 binding to HeLa cells. E,F) SDS-PAGE of the isolated fractions. n=6 ANOVA test **,
p-value < 0.001.
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the eukaryotic surface.
Methods
Bacterial strains, eukaryotic cell lines and growth conditions
Lactobacillus salivarius Lv72 (CECT 8259) (Colección
Española de Cultivos Tipo (CECT), Valencia, Spain) was
isolated from the vaginal fluid of a healthy woman of re-
productive age [1]. It was propagated in MRS broth
(Becton, Franklin lakes, USA) set at 37°C without agita-
tion in a 10% (v/v) CO2 enriched atmosphere. Whenappropriate, 1.5% (w/v) agar was added to the liquid
medium.
HeLa (ATCC CCL-2) and HT-29 (ATCC HTB-38) cell
lines (LGC-Standards, Molsheim, France) were grown in
Dulbecco’s Modified Eagle’s minimal essential medium
(DMEM) (GibcoBRL, Eragny, France) supplemented with
10% (w/v) fetal bovine serum (GibcoBRL) and with peni-
cillin G/streptomycin (5000 IU/ml, 5000 μg/ml) (Sigma-
Aldrich Chemie GmbH, Buchs, Switzerland). Cultures were
incubated in 25 cm2 tissue culture flasks (Nunc, Roskilde,
Denmark) at 37°C in a 5% (v/v) CO2 atmosphere until
Figure 5 Inhibition of L. salivarius Lv72 attachment to HeLa
cells by different concentrations of purified OppA. Lv72 was
co-incubated in the presence of OppA (■) or bovine serum albumin
(used as a negative control) (grey sqaure). n=5 ANOVA test *,
p-value < 0.05.
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seeded in 24-well culture plates (Nunc) and cultivated, with
a daily change of the culture medium until confluence.
Fluorescein labeling
Fluorescein isothiocyanate (FITC) (Sigma-Aldrich) label-
ing was performed on overnight cultures washed four
times with PBS buffer (GibcoBRL) and resuspended in a
0.1 mg/ml FITC solution to an A600 of 0.5; incubation in
the dark at 37°C under agitation proceeded for 2 h and
the bacterial suspensions were centrifuged and washed 4
times with PBS to eliminate the excess FITC.
Adherence assays
Adhesion of L. salivarius Lv72 to HeLa monolayers was
tested following the procedure described by Tallon and
co-workers using 25 FITC-labelled bacteria per eukaryotic
cell [67]. At the end of the experiment, epithelial cells were
disaggregated with trypsin and the fluorescence of the lac-
tobacilli attached to them was quantified in a Perkin Elmer
LS55 fluorometer set at 488 nm (excitation) and 560 nm
(emission). Data were normalized using the adhesion
values without any additive which was given the arbitrary
value of 1. Assays were performed at least in triplicate and
the data are expressed as the mean ± SD.
Adherence interference experiments were performed
with heparin, HS, CS A, CS B (DS) and CS C (Sigma-
Aldrich) and their combinations at concentrations ranging
between 0.01 and 100 μg/ml (final concentration), added to
the monolayers immediately before the bacterial cultures.
Complementarily, the surface GAGs of HeLa and HT-29
cells and the bacterial surface proteins of L. salivarius Lv72as well as OppA were extracted and purified (see below)
and also used in adherence interference experiments. The
dissociation constant estimations were obtained through a
non-linear regression using the program Statistica (StatSoft,
Inc. USA) by means of the equation of Langmuir [68].
Enzymatic digestion of eukaryotic cell-surface GAGs
Hydrolysis of HS from cell cultures was achieved by
overnight incubation at 37°C in DMEM minimal medium
with a mix of 500 mU/ml (final concentration) of each
heparinases I, II and III (Sigma-Aldrich). Elimination of
CS/DS was obtained through incubation of the cell cul-
tures with 250 mU/ml of chondroitinase ABC (Sigma-
Aldrich) at 37°C for 3 h. Elimination of both GAGs was
achieved through successive incubation of the cell cultures
with the enzymatic mixes, with an intermediate washing
with PBS buffer. The reactions were stopped with 2
washes in PBS buffer and the cell cultures were immedi-
ately submerged in DMEM and subjected to adherence
assays with L. salivarius Lv72 as described in a previous
paragraph.
GAG extraction and purification
HeLa and HT-29 cells were propagated in 10 cm diameter
tissue plates (Nunc) until confluence. The monolayers were
washed twice with PBS and incubated in 6 ml of a 6 M
guanidinium chloride, 3 mM DTT (Sigma-Aldrich) solution
in 50 mM Tris–HCl (pH 8) at 60°C for 1 h with agitation.
Afterwards, 15 ml of a 6.7 mM CaCl2 (Merck, Lion, France)
solution in Tris–HCl (pH 8) plus 1.5 μg/ml proteinase K
(Sigma-Aldrich) were added and the culture supernatant
was recovered and incubated overnight at 56°C. Subse-
quently, the proteinase K was inactivated by incubation at
100°C for 10 min; 5.7 volumes of ethanol (VWR) were
added followed by incubation at 4°C for 2 h. The precipi-
tated GAGs were pelleted at 4000 x g for 15 min, air-dried
and resuspended in 1 ml of a 0.2 M NaOH, 0.8% sodium
borohydride (Merck) solution and agitated overnight at
room temperature. The resulting suspension was centri-
fuged at 12,000 x g and the GAGs present in the super-
natant were precipitated with ethanol (85%), dried and
resuspended in 1 ml distilled water. The GAG concentra-
tion was determined spectrophotometrically as described
previously [69]. The partial digestion of HS and CS was
performed as described above.
Extraction of L. salivarius Lv72 surface proteins and
heparin-affinity chromatography
L. salivarius Lv72 was grown until mid-exponential phase,
washed twice with buffer A (50 mM Tris–HCl, 150 mM
NaCl; pH 7.5) and the bacterial cell pellet was resuspended
in the same buffer containing a commercial cocktail of
EDTA-free protease inhibitors (Roche, Basel, Switzerland),
1 mM MgCl2, 5 mg/ml lysozyme (Sigma-Aldrich) and 0.05
Figure 6 Disaccharide units of GAGs: CS A is sulfated at C4 of GalNAc (pointed by an arrow). CS C is sulfated at C6 of GalNAc (pointed by
an arrow). In CS B (DS) GlcA is epimerized to IdoA, and can be sulfated at C4 or C6 of GalNAc and C2 of IdoA. HS includes GlcA and IdoA
residues and can be sulfated at C2 of the uronic acid residue and at N, C6 and C3 of GlcN; heparin is basically constituted of IdoA-GlcN
oversulfated disaccharides.
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night at 4°C. Cells were mechanically disrupted by re-
peated passage through a French press (SLM Aminco Inc),
the pellet was washed twice with buffer A and subjected
to overnight digestion with 5 mg/ml lysozyme in the
presence of protease inhibitors at 4°C, followed by incu-
bation with 5% Triton X-100 (Sigma-Aldrich) for 1 h at
room temperature. The final solution was centrifugatedat 10,000 rpm for 30 min and the supernatant was applied
to a 1 ml heparin affinity column (GE, Buckinghamshire,
England) connected to a FPLC system (GE). Bound pro-
teins were eluted with a continuous 0 – 2 M NaCl gradi-
ent in 50 mM Tris–HCl buffer (pH 7.5) and aliquots of
the protein fractions were used in HeLa/Lactobacillus ad-
herence assays. Those that interfered most were subjected
to anion exchange chromatography in a Q-sepharose FF
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gradient in 50 mM Tris–HCl buffer (pH 7.5) and the
resulting fractions were subjected to adherence interfer-
ence assays as described above. The protein concentrations
were determined with the Pierce BCA Protein Assay Kit
(Thermo Scientific, Rockford, USA) following the instruc-
tions of the manufacturer. SDS-PAGE [66] was performed
in a “Miniprotean III” system (Bio-Rad, Hercules, USA).
The proteins were stained with Comassie R-250 blue [70]
or with a protein silver staining kit (GE). The band of
interest was excised from the gels, digested with porcine
trypsin and the resulting peptides were analyzed by
MALDI-TOF/(MS) at the Proteomic Service of the
Centro Nacional de Biotecnología (CNB-CSIC, Madrid).Construction of expression plasmids and purification of
the oligopeptide permease A protein (OppA)
The oppA sequence of L. salivarius Lv72 [BankIt1609288
Lactobacillus KC703973] was amplified using primer
pairs deduced from the oppA sequence of L. salivarius
UCC118 (LSL_1882). The sequence encoding the OppA
signal peptide was omitted to ease protein purification.
The PCR product was purified and cloned into the vector
pRSET-B digested with NdeI and BamHI (Fermentas,
Thermo Scientific). The resulting plasmid was transformed
to E. coli BL21 pLys (DE3)/pLysS cells, which were grown
to an OD600 of 0.6 at 37°C with shaking before addition of
1 mM IPTG (Fermentas, Thermo Scientific) and incuba-
tion was continued at 28°C with shaking overnight. The
cultures were harvested, resuspended in 25 mM Tris–HCl
(pH 7.5) containing 0.05% Triton-X100 and disrupted by
sonication. The supernatant proteins were fractionated
after passage through a heparin-affinity chromatography
column as described above and the purified OppA protein
was used for adhesion assays at concentrations ranging
from 1 to 50 μg/ml.Statistical analysis
Statistical analysis was performed using GraphPad Prism
Software version 5.00 for Windows (San Diego, California,
USA). The groups were compared using one-way analysis
of variance (ANOVA) followed by the student-Newman-
Keuls multiple comparison post hoc analysis. A p-value of
less than 0.05 was considered significant.
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